Summary
The investigation was carried out on 30 subjects: 21 obese subjects and 9 normal weight controls. Twelve of the obese subjects and the 9 controls received 1 g tolbutamide i.v.; the other 9 obese subjects received 1.5 g tolbutamide, all in fasting condition. Plasma glucose, FFA, cortisol, serum IRI, and IRHGH were measured before and 15, 30, 60, 90 and 120 min after tolbutamide administration. A blunted response of cortisol and IRHGH to the hypoglycemic stimulus was observed in obese subjects receiving 1 g tolbutamide. The blunted response was reversed when 1.5 g tolbutamide was injected. Glucose levels were significantly higher at 60 min in the obese who received 1 g tolbutamide as compared to the controls, and were significantly lower 30, 60 and 90 min after the tolbutamide injection in obese who received 1.5 g tolbutamide. FFA showed significantly higher values 90 and 120 min after the injection in both groups of obese subjects: dose dependency was not observed. Insulin values were significantly higher 15 min after tolbutamide injection in the obese receiving 1.5 g tolbutamide when compared to those receiving 1 g and to the controls. The blunted plasma cortisol and serum IRHGH responses were reversed when larger doses were used. Some possible explanations for the results are discussed: a hypothalamo-pituitary underresponsiveness, a lower ratio of biologically active versus biologically unactive IRI, and peripheric insulin resistance in obesity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ball M. F., El-Khodary A. Z., Canary J. J.: Growth Hormone Response in the Thinned Obese — J. clin. Endocr.34, 498, 1972.
Beck P., Koumans J. H., Winterling C. A., Stein M. F., Daughaday W. H., Kipnis D. M.: Studies of Insulin and Growth Hormone Secretion in Human Obesity — J. Lab. clin. Med.64, 654, 1964.
Cryer P. E., Coran A. G., Keenan B. S., Sode J.: Cessation of Growth Hormone Secretion Associated with Acute Elevation of the Serum-Free Fatty Acid Concentration — Metabolism21, 867, 1972.
De Moor P., Steeno O., Raskin M. Hendrikx A.: Fluorimetric Determination of Free Plasma 11-Hydroxycorticosteroids in Man — Acta endoct. (Kbh.)33, 297, 1960.
Duncan G. G.: Diseases of Metabolism — W. B. Saunders, Philadelphia, 1964; p. 1072.
Fehlig P., Marliss E., Cahill G. F. Jr.: Plasma Amino Acid Levels and Insulin Secretion in Obesity — New Engl. J. Med.281, 811, 1969.
Frohman L. A., Bernardis L. L., Schnatz J. D., Burek L.: Plasma Insulin and Triglyceride Levels after Hypothalamic Lesions in Weanling Rats — Amer. J. Physiol.216, 1496, 1969.
Hales C. N., Randle P. J.: Immunoassay of Insulin with Insulin-Antibody Precipitate — Biochem. J.88, 137, 1963.
Harell A., Oberman Z., Herzberg M., Laurian L.: Changes in Serum Glucose and Free Fatty Acids after Administration of Tolbutamide in Obese Women — Israel J. med. Sci.6, 304, 1970.
Hoffman W. S.: Rapid Photoelectric Method for Determination of Glucose in Blood and Urine — J. biol. Chem.120, 51, 1937.
Laurian L., Oberman Z., Harell A., Cordova T., Herzberg M.: Changes in Serum Cortisol, Glucose and Free Fatty Acid Levels during Tolbutamide-Induced Hypoglycemia in Obese Women — Israel J. med. Sci.8, 1817, 1972.
Lucke C., Adelman N., Glick S. M.: The Effect of Elevated Free Fatty Acids (FFA) on the Sleep-Induced Human Growth Hormone (HGH) Peak — J. clin. Endoct.35, 407, 1972.
Melani F., Rubenstein A. H., Steiner D. F.: Human Serum Proinsulin — J. clin. Invest.49, 497, 1970.
Mosinger F.: Photometric Adaptation of Dole’s Microdetermination of Free Fatty Acids — J. Lipid Res.6, 157, 1965.
Rabinowitz D., Zierler K. L.: Forearm Metabolism in Obesity and its REsponse to Intra-Arterial Insulin. Characterization of Insulin Resistance and Evidence for Adaptive Hyper-insulinism — J. clin. Invest41, 2181, 1962.
Salans L. B., Knittle J. L., Hirsch J.: The Role of Adipose Cell Enlargement in the Carbohydrate Intolerance of Human Obesity — J. clin. Invest.46, 1112, 1967.
Schalch D. S., Parker M. L.: A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma — Nature (Lond.)203, 1141, 1964.
Schwarz F., van Riet H. G., Schopman W.: Serum Growth Hormone and Energy Supply in Fasting Obese Patients — Metabolism15, 194, 1966.
Stern J. S., Batchelor B. R., Hollander N., Cohen C. K., Hirsch J.: Adipose-Cell Size and Immunoreactive Insulin Levels in Obese and Normal-Weight Adults — Lancet2, 948, 1972.
Theodoridis C. G., Brown G. A., Chance G. W., Rayner P. H.: Growth-Hormone Response to Oral Glucose in Children with Simple Obesity — Lancet1, 1068, 1969.
Yalow R. S., Glick S. M., Roth J., Berson S. A.: Plasma Insulin and Growth Hormone Levels in Obesity and Diabetes — Ann. N. Y. Acad. Sci.131, 357, 1965.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Laurian, L., Cordova, T., Oberman, Z. et al. Changes in plasma glucose, free fatty acids (FFA), cortisol, immunoreactive human growth hormone (IRHGH) and immunoreactive insulin (IRI) after tolbutamide-induced hypoglycemia in obese subjects. Acta diabet. lat 11, 446–456 (1974). https://doi.org/10.1007/BF02624584
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02624584